Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Abstract Breast cancer (BC) is a heterogeneous disease, traditionally classified by hormone receptor and HER2 (human epidermal growth factor receptor 2) status. HER2-low, characterized by low HER2 expression without gene amplification, recently gained attention. While new therapies are promising, it...
Saved in:
Main Authors: | Maria Elena Lacruz, Saskia Thies, Andrea Schmidt-Pokrzywniak, Ian Wittenberg, Tobias Engler, Fabian Reinwald, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Bianca Franke, Kerstin Weitmann, Atanas Ignatov |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88394-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01) -
Effect of “Time To Surgery” on the Endometrial Cancer Prognosis
by: Engin Celik, et al.
Published: (2022-03-01) -
Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer
by: Yilong Huang, et al.
Published: (2025-02-01) -
Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study
by: Seyed Mohamad Sadegh Mousavi-kiasary, et al.
Published: (2025-02-01) -
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification
by: Youngkyung Jeon, et al.
Published: (2024-01-01)